Abiraterone Acetate Tablets（Ⅱ）(Chengdu Suncadia Medicine)

醋酸阿比特龙片（Ⅱ）（成都盛迪医药）

Report date: 2025/09/23 11:24:21

Base Information

Drug NameAbiraterone Acetate Tablets（Ⅱ）(Chengdu Suncadia Medicine)
Drug Alias NameAbiraterona乙酸阿比特龙酯Abiraterone acetate fine particle阿比特隆Abirateronum +[16] 
ClassificationSmall molecules > SteroidsSmall molecules > Prodrug
Mechanisms of ActionSteroid 17-alpha-hydroxylase inhibitors
TargetsSteroid 17-alpha-hydroxylase
Therapy Area/IndicationsSolid tumoursProstatic Neoplasms, Castration-ResistantProstatic Neoplasms
Global Approved IndicationsProstatic Neoplasms, Castration-Resistant
Approved Indications in ChinaProstatic Neoplasms, Castration-Resistant
Original Approved Country/TerritoryMainland China
Original Approved Date2023/12/26
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesChengdu Suncadia Medicine Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChengdu Suncadia Medicine Co LtdJiangsu Hengrui Medicine Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursProstatic Neoplasms, Castration-ResistantProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG